Translational Development Acquisition Corp. (TDAC): fair value, margin of safety and Wheel Score

Is TDAC undervalued?

TDAC closed at 10.91 on 5 Nov 2026 against a GLS average fair value of 11.77 - 7.3% below fair value, which our scans read as "fairly priced". 2 of 5 models are above the current price. There is no discount to lean on here, so the margin of safety is not the reason to look at the stock.

The 5 models disagree widely: EPV gives 3.65 while GLS Growth gives 20.11. A spread that wide means the average is sensitive to which methods you trust; the model table below shows where each one lands, and the Quote page lets you switch any of them off.

The nightly engine files TDAC under Speculative - it is losing money or its Piotroski health score is 3 or lower - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for TDAC

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

Quality and financial health

Financial health is weak: TDAC passes 3 of the nine Piotroski tests. Our scans drop the stock at the health filter; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is low at 1.7 out of 10: returns on capital, margins or the balance sheet have not shown a lasting edge yet - often a young company, a thin-margin business or one that has only recently turned profitable.

Returns on capital are thin or negative - ROIC 3.6%, ROE 3.6%, ROA 3.5% - with debt at 0.00 times equity and negative free cash flow.

Translational Development Acquisition Corp. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain.

Institutional ownership scores 10/10, insider activity 10/10 and Congressional trading 5/10 on the GLS smart-money scales.

Wheel Score 15: No options

TDAC has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business. It fails the first Wheel Trade Filter (options that actually trade), so the score stays under 70 and is shown as "No options" (15 here). The valuation and quality numbers still apply to owning the shares outright.

Volume runs at 0k shares a day on a market cap of $269M, with a beta of 0.01 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score rates that fair.

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls: a stock must pass all 9 Wheel Trade Filters to score 70, and the score then ranks the ones that pass; the Sunday Scan is the top 10. It is updated nightly and is not a recommendation. How the Wheel Score works · the walkthrough lesson shows how it fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for TDAC in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Shell Companies

The 12 companies below are the closest to Translational Development Acquisition Corp. by market cap within the Shell Companies industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

⚖ Compare TDAC with 7 of them   All Financial Services stocks →